Verge Genomics careers

Verge Genomics is a next-generation drug discovery company that is using human genomic data to defeat neurodegeneration. In just the last year, we have built the field's largest human brain genomic database, closed two pharma partnerships, and made important breakthroughs on two novel therapeutic targets in ALS patient neurons.

Founded by scientists from leading neuro-genomics labs, the Verge team is 14 people including 12 Ph.D.s in machine learning, neuroscience, applied math, biophysics, statistics, and computational biology from UCLA, Stanford, Oxford, and UCSF, two former professors, and two pharma veterans who have taken drugs from idea to clinic (including a leading schizophrenia drug in market and a non-addictive pain opiate).